Cabozantinib

Product name: Cabozantinib
Synonyms: Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351);N-(4-(6,7-diMethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide(CAS：849217-68-1);XL-186;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide Cabozantinib (XL184, BMS-907351);1,1-cyclopropanedicarboxamide, n'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-n-(4-fluorophenyl)-;Cabozantinib, >=98%
CAS:849217-68-1
MF:C28H24FN3O5
MW:502
Standard: Medical grade
Content: 99.5%
Appearance: white powder
Packing: 200G / aluminum foil bag can be split
Category: Pharmaceutical raw materials
Industry: Medicine
Area: Anti-cancer small molecule inhibitors
Delayed products: Cabotinib capsules
Use: Targets inhibit MET, VEGFR2 and RET signaling pathways and play an antitumor effect, it can kill tumor cells, reduce metastasis and inhibit angiogenesis.
Anticancer drugs: including sunitinib, erlotinib, Foretinib APIs and intermediates; anti-cancer drugs including sunitinib, erlotinib, Foretinib APIs and Intermediates; Materials; Small Molecule Inhibitors; Inhibitors; Small Molecule Inhibitors, Natural Products; Pharmaceutical Preparations; Small Molecule Targeted Drugs [For Research Use Only]; Protein Tyrosine Kinase; ; Signal transduction pathway kinase inhibitors; APIs